Ziopharm Message Board - Msg: 31047823

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ziopharm

ZIOP 0.866

-0.9%

Jan 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: PLegee	3/28/2017 9:48:49 AM
	Read Replies (1) of 14

Apparently, ZIOP has finally recognized the error of their ways and decided to remedy it. Just announced yesterday, Amy Trevvett will assume role of Vice President of Investor Relations and Corporate Communications. Additionally, “as part of our focus on communications with our shareholders and the investment community, we will be hosting quarterly conference calls beginning this May, in conjunction with our first quarter 2017 earnings report. We look forward to sharing our progress throughout this year and beyond, as our multiple immunotherapy platforms continue to move forward into and through clinic." Imagine that, communications with shareholders and now quarterly conf calls. Now maybe Wall Street will soon give us a much needed second look. We have the technological potential, the upcoming Ph 3 trial registration would also support that opinion. Need to get the cash situation resolved; still an outstanding issue.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next